Alethia de Leon is a seasoned Life Sciences and Healthcare Board Member, Entrepreneur, and Investor. They served as a Seed Investor and Board Member at Clade Therapeutics from 2020 to 2021 and have held various roles, including Founder and CEO of Senes Science GmbH from 2015 to 2020, and Head of Search & Evaluation, Neuroscience at Novartis from 2009 to 2015. Currently, Alethia is a Member of the Investment Advisory Board for the Swiss Entrepreneurs Foundation and an Innovation Council Member at Innosuisse. They earned a Master’s and Bachelor’s degree in Chemical Engineering from the Massachusetts Institute of Technology and an MBA from Harvard Business School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices